Descriere YEO:
Pe YEO găsești Pharmanomics: How Big Pharma Destroys de la Nick Dearden, în categoria Business & Economics.
Indiferent de nevoile tale, Pharmanomics: How Big Pharma Destroys Global Health - Nick Dearden din categoria Business & Economics îți poate aduce un echilibru perfect între calitate și preț, cu avantaje practice și moderne.
Preț: 133.67 Lei
Caracteristicile produsului Pharmanomics: How Big Pharma Destroys
- Brand: Nick Dearden
- Categoria: Business & Economics
- Magazin: libris.ro
- Ultima actualizare: 25-11-2024 01:40:54
Comandă Pharmanomics: How Big Pharma Destroys Online, Simplu și Rapid
Prin intermediul platformei YEO, poți comanda Pharmanomics: How Big Pharma Destroys de la libris.ro rapid și în siguranță. Bucură-te de o experiență de cumpărături online optimizată și descoperă cele mai bune oferte actualizate constant.
Descriere magazin:
Investigative journalist
Nick Dearden digs down into the way we produce our medicines and finds that Big
Pharma is failing us, with catastrophic consequences. Big
Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the
Global South. But this is only the latest episode in a long history of financialising medicine--from Purdue\'s rapacious marketing of highly addictive OxyContin through Martin Shkreli\'s hiking the price of a lifesaving drug to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication. Since the 1990s, Big
Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response,
Dearden offers a pathway to a fairer, safer system for all.